(3) hour domestic violence training course within 3 years of initial licensure, for primary care physicians;
(4.5) hours relating to the use of KASPER, pain management, addiction disorders, or a combination of two or more those (must be Board approved; for controlled substance prescribers);
(12) hours related to addiction medicine (for those authorized to prescribe or administer Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone; must be Board approved);
(1.5) hours on the recognition and prevention of pediatric abusive head trauma (one-time requirement within 5 years of licensure for pediatricians, radiologists, family practitioners, and emergency medicine and urgent care physicians; must be Board approved).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://kbml.ky.gov/cme/Pages/default.aspx

(5) pharmacology contact hours, and (1.5) of these must be in the dual subject of pharmacology and either pain management, or addiction disorders;
(4) hours on addiction disorders;
(3) hours on domestic violence, and elder abuse, neglect and exploitation on adult and child victims (within 3 years of licensure);
(1.5) hours on the recognition and prevention of pediatric abusive head trauma (within 3 years of licensure);
(2) hours on suicide prevention (within 3 years of licensure).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://kbn.ky.gov/continuing-education/Pages/Continuing-Education-Requirements.aspx

(12) hours related to addiction medicine (for those authorized to prescribe or administer Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone; must be Board-approved);
(7.5) hours relating to: a. controlled substance diversion; b. pain management; c. addiction disorders; d. the use of KASPER; or e. any combination of two or more of these subjects (must be Board-approved);
(1.5) hours on the recognition and prevention of pediatric abusive head trauma (one-time requirement within the first 2 years of initial licensure; must be Board-approved);
(1) hour on human immunodeficiency virus and acquired immunodeficiency syndrome (one-time requirement within the first 2 years of initial licensure).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://apps.legislature.ky.gov/law/kar/titles/201/009/360/
https://kbml.ky.gov/ah/Pages/Physician-Assistant.aspx"